Orwin John A exercised Options for 1,300 ANAPTYSBIO shares at $0, leaving him with 17,995 shares and zero derivative securities.

Key Highlights

  • Orwin John A’s exercise represented about 7.2% of his resulting ANAPTYSBIO share holding.
  • The transaction eliminated 100.0% of his prior derivative securities holding.
  • Transaction code M classified the event as an option exercise dated September 15, 2026.

ANAPTYSBIO, INC. (NASDAQ: ANAB) is a biotechnology company. Orwin John A exercised options for 1,300 ANAPTYSBIO shares at $0 on September 15, 2026, leaving him with 17,995 shares.

1,300 Options Exercised at $0

The 1,300 derivative securities covered by the transaction were exercised on the same date. The transaction amounted to about 7.2% of Orwin John A’s resulting share position. His derivative-securities balance after the exercise was zero, representing about 100.0% of his prior derivative securities holding.